CA2805247C - Nanopore-facilitated single molecule detection of nucleic acids - Google Patents
Nanopore-facilitated single molecule detection of nucleic acids Download PDFInfo
- Publication number
- CA2805247C CA2805247C CA2805247A CA2805247A CA2805247C CA 2805247 C CA2805247 C CA 2805247C CA 2805247 A CA2805247 A CA 2805247A CA 2805247 A CA2805247 A CA 2805247A CA 2805247 C CA2805247 C CA 2805247C
- Authority
- CA
- Canada
- Prior art keywords
- probe
- nanopore
- oligonucleotide
- target
- mir
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 150000007523 nucleic acids Chemical class 0.000 title description 37
- 102000039446 nucleic acids Human genes 0.000 title description 32
- 108020004707 nucleic acids Proteins 0.000 title description 32
- 238000004557 single molecule detection Methods 0.000 title description 6
- 239000000523 sample Substances 0.000 claims abstract description 192
- 239000002679 microRNA Substances 0.000 claims abstract description 140
- 108091070501 miRNA Proteins 0.000 claims abstract description 118
- 108091034117 Oligonucleotide Proteins 0.000 claims abstract description 101
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims abstract description 22
- 230000000295 complement effect Effects 0.000 claims abstract description 21
- 238000000034 method Methods 0.000 claims description 80
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 39
- 108020004414 DNA Proteins 0.000 claims description 37
- 230000005945 translocation Effects 0.000 claims description 37
- 239000002773 nucleotide Substances 0.000 claims description 36
- 125000003729 nucleotide group Chemical group 0.000 claims description 33
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 26
- 229920001184 polypeptide Polymers 0.000 claims description 25
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 25
- 108091093037 Peptide nucleic acid Proteins 0.000 claims description 20
- 239000000203 mixture Substances 0.000 claims description 19
- 102000053602 DNA Human genes 0.000 claims description 13
- 101710092462 Alpha-hemolysin Proteins 0.000 claims description 12
- 150000001413 amino acids Chemical class 0.000 claims description 12
- 238000004458 analytical method Methods 0.000 claims description 8
- 230000008569 process Effects 0.000 claims description 8
- 229920001577 copolymer Polymers 0.000 claims description 6
- 229920001519 homopolymer Polymers 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 239000012634 fragment Substances 0.000 claims description 5
- 229920000642 polymer Polymers 0.000 claims description 5
- 238000006467 substitution reaction Methods 0.000 claims description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 4
- 229910021389 graphene Inorganic materials 0.000 claims description 4
- 108020005187 Oligonucleotide Probes Proteins 0.000 claims description 3
- 229920000140 heteropolymer Polymers 0.000 claims description 3
- 239000002751 oligonucleotide probe Substances 0.000 claims description 3
- 230000009977 dual effect Effects 0.000 claims 4
- 125000003275 alpha amino acid group Chemical group 0.000 claims 3
- 238000001514 detection method Methods 0.000 abstract description 51
- 206010028980 Neoplasm Diseases 0.000 abstract description 18
- 201000011510 cancer Diseases 0.000 abstract description 11
- 238000005516 engineering process Methods 0.000 abstract description 8
- 210000004369 blood Anatomy 0.000 abstract description 7
- 239000008280 blood Substances 0.000 abstract description 7
- 230000001976 improved effect Effects 0.000 abstract description 7
- 238000011002 quantification Methods 0.000 abstract description 6
- 230000004069 differentiation Effects 0.000 abstract description 5
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 108091033773 MiR-155 Proteins 0.000 description 79
- 108700011259 MicroRNAs Proteins 0.000 description 68
- 239000011148 porous material Substances 0.000 description 63
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 32
- 239000000243 solution Substances 0.000 description 31
- 108091028376 let-7a-5 stem-loop Proteins 0.000 description 30
- 201000005202 lung cancer Diseases 0.000 description 30
- 208000020816 lung neoplasm Diseases 0.000 description 30
- 108091007423 let-7b Proteins 0.000 description 29
- 108091091807 let-7a stem-loop Proteins 0.000 description 28
- 108091057746 let-7a-4 stem-loop Proteins 0.000 description 28
- 108091024393 let-7a-6 stem-loop Proteins 0.000 description 28
- 108091091174 let-7a-7 stem-loop Proteins 0.000 description 28
- 108091007772 MIRLET7C Proteins 0.000 description 12
- 239000003228 hemolysin Substances 0.000 description 12
- 108091090568 miR-39 stem-loop Proteins 0.000 description 12
- 108091056739 miR-39-1 stem-loop Proteins 0.000 description 12
- 108091039160 miR-39-2 stem-loop Proteins 0.000 description 12
- 108090000623 proteins and genes Proteins 0.000 description 12
- 102000004169 proteins and genes Human genes 0.000 description 11
- 238000000926 separation method Methods 0.000 description 11
- 235000001014 amino acid Nutrition 0.000 description 10
- 235000018102 proteins Nutrition 0.000 description 10
- 238000003757 reverse transcription PCR Methods 0.000 description 10
- 239000000232 Lipid Bilayer Substances 0.000 description 9
- 230000035945 sensitivity Effects 0.000 description 9
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 8
- 238000011529 RT qPCR Methods 0.000 description 8
- 238000002512 chemotherapy Methods 0.000 description 8
- 230000014509 gene expression Effects 0.000 description 8
- 208000000649 small cell carcinoma Diseases 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 7
- 230000003993 interaction Effects 0.000 description 7
- 239000000463 material Substances 0.000 description 6
- 238000012544 monitoring process Methods 0.000 description 6
- 108091023037 Aptamer Proteins 0.000 description 5
- 108090000862 Ion Channels Proteins 0.000 description 5
- 102000004310 Ion Channels Human genes 0.000 description 5
- 238000002123 RNA extraction Methods 0.000 description 5
- 238000010494 dissociation reaction Methods 0.000 description 5
- 230000005593 dissociations Effects 0.000 description 5
- -1 microRNAs Chemical class 0.000 description 5
- 238000005192 partition Methods 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- 235000009697 arginine Nutrition 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 238000013399 early diagnosis Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 108091023663 let-7 stem-loop Proteins 0.000 description 4
- 108091063478 let-7-1 stem-loop Proteins 0.000 description 4
- 108091049777 let-7-2 stem-loop Proteins 0.000 description 4
- 230000036961 partial effect Effects 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 238000003753 real-time PCR Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 108091005703 transmembrane proteins Proteins 0.000 description 4
- 102000035160 transmembrane proteins Human genes 0.000 description 4
- 239000004475 Arginine Substances 0.000 description 3
- 108091006146 Channels Proteins 0.000 description 3
- 239000003298 DNA probe Substances 0.000 description 3
- 239000013614 RNA sample Substances 0.000 description 3
- 101900127397 Staphylococcus aureus Alpha-hemolysin Proteins 0.000 description 3
- 108010090804 Streptavidin Proteins 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 3
- 238000009396 hybridization Methods 0.000 description 3
- 238000011068 loading method Methods 0.000 description 3
- 235000018977 lysine Nutrition 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 108020004999 messenger RNA Proteins 0.000 description 3
- 238000002493 microarray Methods 0.000 description 3
- 208000002154 non-small cell lung carcinoma Diseases 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 102000040430 polynucleotide Human genes 0.000 description 3
- 108091033319 polynucleotide Proteins 0.000 description 3
- 239000002157 polynucleotide Substances 0.000 description 3
- 238000002271 resection Methods 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 description 3
- FZWGECJQACGGTI-UHFFFAOYSA-N 2-amino-7-methyl-1,7-dihydro-6H-purin-6-one Chemical compound NC1=NC(O)=C2N(C)C=NC2=N1 FZWGECJQACGGTI-UHFFFAOYSA-N 0.000 description 2
- OIVLITBTBDPEFK-UHFFFAOYSA-N 5,6-dihydrouracil Chemical compound O=C1CCNC(=O)N1 OIVLITBTBDPEFK-UHFFFAOYSA-N 0.000 description 2
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
- 238000000018 DNA microarray Methods 0.000 description 2
- 108091081406 G-quadruplex Proteins 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 2
- UBORTCNDUKBEOP-UHFFFAOYSA-N L-xanthosine Natural products OC1C(O)C(CO)OC1N1C(NC(=O)NC2=O)=C2N=C1 UBORTCNDUKBEOP-UHFFFAOYSA-N 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- 229910052581 Si3N4 Inorganic materials 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- UBORTCNDUKBEOP-HAVMAKPUSA-N Xanthosine Natural products O[C@@H]1[C@H](O)[C@H](CO)O[C@H]1N1C(NC(=O)NC2=O)=C2N=C1 UBORTCNDUKBEOP-HAVMAKPUSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 208000009956 adenocarcinoma Diseases 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 230000031018 biological processes and functions Effects 0.000 description 2
- 229920001400 block copolymer Polymers 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 210000001808 exosome Anatomy 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 235000014304 histidine Nutrition 0.000 description 2
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 201000005296 lung carcinoma Diseases 0.000 description 2
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000001394 metastastic effect Effects 0.000 description 2
- 206010061289 metastatic neoplasm Diseases 0.000 description 2
- 230000011987 methylation Effects 0.000 description 2
- 238000007069 methylation reaction Methods 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 108091027963 non-coding RNA Proteins 0.000 description 2
- 238000010606 normalization Methods 0.000 description 2
- 210000005259 peripheral blood Anatomy 0.000 description 2
- 239000011886 peripheral blood Substances 0.000 description 2
- 230000002028 premature Effects 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000000306 recurrent effect Effects 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- HQVNEWCFYHHQES-UHFFFAOYSA-N silicon nitride Chemical compound N12[Si]34N5[Si]62N3[Si]51N64 HQVNEWCFYHHQES-UHFFFAOYSA-N 0.000 description 2
- 238000004088 simulation Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 239000000107 tumor biomarker Substances 0.000 description 2
- UBORTCNDUKBEOP-UUOKFMHZSA-N xanthosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(NC(=O)NC2=O)=C2N=C1 UBORTCNDUKBEOP-UUOKFMHZSA-N 0.000 description 2
- ZAYHVCMSTBRABG-UHFFFAOYSA-N 5-Methylcytidine Natural products O=C1N=C(N)C(C)=CN1C1C(O)C(O)C(CO)O1 ZAYHVCMSTBRABG-UHFFFAOYSA-N 0.000 description 1
- ZAYHVCMSTBRABG-JXOAFFINSA-N 5-methylcytidine Chemical compound O=C1N=C(N)C(C)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 ZAYHVCMSTBRABG-JXOAFFINSA-N 0.000 description 1
- LRSASMSXMSNRBT-UHFFFAOYSA-N 5-methylcytosine Chemical compound CC1=CNC(=O)N=C1N LRSASMSXMSNRBT-UHFFFAOYSA-N 0.000 description 1
- OGHAROSJZRTIOK-KQYNXXCUSA-O 7-methylguanosine Chemical compound C1=2N=C(N)NC(=O)C=2[N+](C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OGHAROSJZRTIOK-KQYNXXCUSA-O 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 1
- 108020003215 DNA Probes Proteins 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 108010006464 Hemolysin Proteins Proteins 0.000 description 1
- 101000806511 Homo sapiens Protein DEPP1 Proteins 0.000 description 1
- 108700000788 Human immunodeficiency virus 1 tat peptide (47-57) Proteins 0.000 description 1
- UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
- 229930010555 Inosine Natural products 0.000 description 1
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108091092724 Noncoding DNA Proteins 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 102000043276 Oncogene Human genes 0.000 description 1
- 108700020796 Oncogene Proteins 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 101710124239 Poly(A) polymerase Proteins 0.000 description 1
- 102100037469 Protein DEPP1 Human genes 0.000 description 1
- 235000013929 Psidium pyriferum Nutrition 0.000 description 1
- 244000236580 Psidium pyriferum Species 0.000 description 1
- 108091034057 RNA (poly(A)) Proteins 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 108020004459 Small interfering RNA Proteins 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 108020004566 Transfer RNA Proteins 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000001594 aberrant effect Effects 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 150000001484 arginines Chemical class 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 238000005415 bioluminescence Methods 0.000 description 1
- 230000029918 bioluminescence Effects 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- ZPTBLXKRQACLCR-XVFCMESISA-N dihydrouridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)CC1 ZPTBLXKRQACLCR-XVFCMESISA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 230000005518 electrochemistry Effects 0.000 description 1
- 238000002001 electrophysiology Methods 0.000 description 1
- 230000007831 electrophysiology Effects 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229960003786 inosine Drugs 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 108091050724 let-7b stem-loop Proteins 0.000 description 1
- 108091030917 let-7b-1 stem-loop Proteins 0.000 description 1
- 108091082924 let-7b-2 stem-loop Proteins 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 108091028606 miR-1 stem-loop Proteins 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000009456 molecular mechanism Effects 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 102000042567 non-coding RNA Human genes 0.000 description 1
- 102000044158 nucleic acid binding protein Human genes 0.000 description 1
- 108700020942 nucleic acid binding protein Proteins 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 230000008488 polyadenylation Effects 0.000 description 1
- 102000054765 polymorphisms of proteins Human genes 0.000 description 1
- 230000001124 posttranscriptional effect Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000002331 protein detection Methods 0.000 description 1
- 238000003762 quantitative reverse transcription PCR Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000025915 regulation of apoptotic process Effects 0.000 description 1
- 230000022983 regulation of cell cycle Effects 0.000 description 1
- 230000016515 regulation of signal transduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 125000000548 ribosyl group Chemical group C1([C@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000004960 subcellular localization Effects 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 229940034208 thyroxine Drugs 0.000 description 1
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
- C12Q1/6825—Nucleic acid detection involving sensors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/48707—Physical analysis of biological material of liquid biological material by electrical means
- G01N33/48721—Investigating individual macromolecules, e.g. by translocation through nanopores
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Urology & Nephrology (AREA)
- Nanotechnology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Hematology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39957810P | 2010-07-14 | 2010-07-14 | |
| US61/399,578 | 2010-07-14 | ||
| PCT/US2011/044082 WO2012009578A2 (en) | 2010-07-14 | 2011-07-14 | Nanopore-facilitated single molecule detection of nucleic acids |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2805247A1 CA2805247A1 (en) | 2012-01-19 |
| CA2805247C true CA2805247C (en) | 2021-08-10 |
Family
ID=45470088
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2805247A Active CA2805247C (en) | 2010-07-14 | 2011-07-14 | Nanopore-facilitated single molecule detection of nucleic acids |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US9395353B2 (enExample) |
| EP (2) | EP2593568B1 (enExample) |
| JP (2) | JP6016792B2 (enExample) |
| AU (1) | AU2011279083B2 (enExample) |
| CA (1) | CA2805247C (enExample) |
| WO (1) | WO2012009578A2 (enExample) |
Families Citing this family (63)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8889348B2 (en) | 2006-06-07 | 2014-11-18 | The Trustees Of Columbia University In The City Of New York | DNA sequencing by nanopore using modified nucleotides |
| US8324914B2 (en) | 2010-02-08 | 2012-12-04 | Genia Technologies, Inc. | Systems and methods for characterizing a molecule |
| US9678055B2 (en) | 2010-02-08 | 2017-06-13 | Genia Technologies, Inc. | Methods for forming a nanopore in a lipid bilayer |
| US9605307B2 (en) | 2010-02-08 | 2017-03-28 | Genia Technologies, Inc. | Systems and methods for forming a nanopore in a lipid bilayer |
| US9194838B2 (en) | 2010-03-03 | 2015-11-24 | Osaka University | Method and device for identifying nucleotide, and method and device for determining nucleotide sequence of polynucleotide |
| CA2805247C (en) * | 2010-07-14 | 2021-08-10 | The Curators Of The University Of Missouri | Nanopore-facilitated single molecule detection of nucleic acids |
| WO2012083249A2 (en) | 2010-12-17 | 2012-06-21 | The Trustees Of Columbia University In The City Of New York | Dna sequencing by synthesis using modified nucleotides and nanopore detection |
| WO2012088339A2 (en) | 2010-12-22 | 2012-06-28 | Genia Technologies, Inc. | Nanopore-based single dna molecule characterization using speed bumps |
| US9581563B2 (en) | 2011-01-24 | 2017-02-28 | Genia Technologies, Inc. | System for communicating information from an array of sensors |
| US9110478B2 (en) | 2011-01-27 | 2015-08-18 | Genia Technologies, Inc. | Temperature regulation of measurement arrays |
| EP3415901A1 (en) * | 2012-01-20 | 2018-12-19 | Genia Technologies, Inc. | Nanopore based molecular detection and sequencing |
| WO2013121201A1 (en) | 2012-02-15 | 2013-08-22 | Oxford Nanopore Technologies Limited | Aptamer method |
| US9850534B2 (en) * | 2012-02-16 | 2017-12-26 | Genia Technologies, Inc. | Methods for creating bilayers for use with nanopore sensors |
| US8986629B2 (en) | 2012-02-27 | 2015-03-24 | Genia Technologies, Inc. | Sensor circuit for controlling, detecting, and measuring a molecular complex |
| EP2836604B1 (en) | 2012-04-09 | 2021-09-15 | The Trustees of Columbia University in the City of New York | Method of preparation of nanopore and uses thereof |
| GB2510719A (en) | 2012-06-15 | 2014-08-13 | Genia Technologies Inc | Chip set-up and high-accuracy nucleic acid sequencing |
| EP2880186B1 (en) | 2012-08-03 | 2019-02-06 | University Of Washington Through Its Center For Commercialization | Compositions and methods for improving nanopore sequencing |
| US9551023B2 (en) | 2012-09-14 | 2017-01-24 | Oxford Nanopore Technologies Ltd. | Sample preparation method |
| US9995728B2 (en) | 2012-11-06 | 2018-06-12 | Oxford Nanopore Technologies Ltd. | Quadruplex method |
| US9605309B2 (en) | 2012-11-09 | 2017-03-28 | Genia Technologies, Inc. | Nucleic acid sequencing using tags |
| US9759711B2 (en) | 2013-02-05 | 2017-09-12 | Genia Technologies, Inc. | Nanopore arrays |
| GB201318465D0 (en) * | 2013-10-18 | 2013-12-04 | Oxford Nanopore Tech Ltd | Method |
| US10648026B2 (en) | 2013-03-15 | 2020-05-12 | The Trustees Of Columbia University In The City Of New York | Raman cluster tagged molecules for biological imaging |
| CA2906007C (en) | 2013-03-15 | 2022-06-21 | The Curators Of The University Of Missouri | Encoded nanopore sensor for multiplex nucleic acids detection |
| CN105102627B (zh) | 2013-03-15 | 2018-10-19 | 纽约哥伦比亚大学理事会 | 用于检测样品中多种预定化合物的方法 |
| WO2014210219A1 (en) | 2013-06-25 | 2014-12-31 | Two Pore Guys, Inc. | Multiplexed biomarker quantitation by nanopore analysis of biomarker-polymer complexes |
| EP3578987A1 (en) | 2013-09-18 | 2019-12-11 | Quantum Biosystems Inc. | Biomolecule sequencing devices, systems and methods |
| JP6334118B2 (ja) * | 2013-09-24 | 2018-05-30 | クオンタムバイオシステムズ株式会社 | 単分子識別方法、装置、及びプログラム |
| JP2015077652A (ja) | 2013-10-16 | 2015-04-23 | クオンタムバイオシステムズ株式会社 | ナノギャップ電極およびその製造方法 |
| US9551697B2 (en) | 2013-10-17 | 2017-01-24 | Genia Technologies, Inc. | Non-faradaic, capacitively coupled measurement in a nanopore cell array |
| US10421995B2 (en) | 2013-10-23 | 2019-09-24 | Genia Technologies, Inc. | High speed molecular sensing with nanopores |
| US9567630B2 (en) | 2013-10-23 | 2017-02-14 | Genia Technologies, Inc. | Methods for forming lipid bilayers on biochips |
| EP3122759B1 (en) | 2014-03-24 | 2022-06-01 | The Trustees of Columbia University in the City of New York | Chemical methods for producing tagged nucleotides |
| US10438811B1 (en) | 2014-04-15 | 2019-10-08 | Quantum Biosystems Inc. | Methods for forming nano-gap electrodes for use in nanosensors |
| WO2015170782A1 (en) | 2014-05-08 | 2015-11-12 | Osaka University | Devices, systems and methods for linearization of polymers |
| JP6601852B2 (ja) * | 2014-07-31 | 2019-11-06 | イルミナ インコーポレイテッド | ハイブリッドナノポアセンサ |
| KR102551897B1 (ko) * | 2014-10-16 | 2023-07-06 | 옥스포드 나노포어 테크놀로지즈 피엘씨 | 폴리머의 분석 |
| CN107109489B (zh) | 2014-10-17 | 2021-11-30 | 牛津纳米孔技术公司 | 纳米孔rna表征方法 |
| CN105842453B (zh) * | 2015-01-12 | 2018-12-25 | 南京理工大学 | 一种基于末端延伸、金纳米粒子和酶三级放大电化学传感器检测dna的方法 |
| CA2986921A1 (en) | 2015-06-02 | 2016-12-08 | Nanopore Diagnostics, Llc | Nucleic acid detection |
| JP6889701B2 (ja) * | 2015-09-24 | 2021-06-18 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | アルファ溶血素バリアント |
| EP3436602B1 (en) | 2016-03-31 | 2024-08-14 | Genia Technologies, Inc. | Nanopore protein conjugates and uses thereof |
| ES2877193T3 (es) | 2016-04-27 | 2021-11-16 | Quantum Biosystems Inc | Sistemas y métodos para la medición y secuenciación de biomoléculas |
| EP3475447B1 (en) | 2016-06-23 | 2021-04-21 | F. Hoffmann-La Roche AG | Formation and calibration of nanopore sequencing cells |
| US11124827B2 (en) | 2016-06-23 | 2021-09-21 | Roche Sequencing Solutions, Inc. | Period-to-period analysis of AC signals from nanopore sequencing |
| CA3030704A1 (en) * | 2016-07-12 | 2018-01-18 | Rijksuniversiteit Groningen | Biological nanopores for biopolymer sensing and sequencing based on frac actinoporin |
| WO2018093976A1 (en) * | 2016-11-16 | 2018-05-24 | Nanopore Diagnostics, Llc | Analysis of nucleic acids using probe with non-linear tag |
| CN116087307B (zh) * | 2017-07-17 | 2025-10-17 | 哈佛大学校董委员会 | 用于分子表征的纳米孔匹配的蛋白质穿梭物及其数据分析方法 |
| WO2019129555A1 (en) | 2017-12-28 | 2019-07-04 | F. Hoffmann-La Roche Ag | Measuring and removing noise in stochastic signals from a nanopore dna sequencing system driven by an alternating signal |
| US11034996B2 (en) | 2018-03-02 | 2021-06-15 | The Curators Of The University Of Missouri | Nucleic acid sequence and capture by formation of an abasic site-derived cross-link |
| WO2019173799A1 (en) * | 2018-03-08 | 2019-09-12 | Caris Science, Inc. | Oligonucleotide probes and uses thereof |
| JP7239965B2 (ja) * | 2018-06-26 | 2023-03-15 | 国立大学法人東京農工大学 | ２種以上の特定オリゴヌクレオチドの有無を判定する判定方法、並びに、前記判定方法を用いて検査対象が小細胞肺がん、胆管がんに罹患している又はそのリスクを有することを判定する方法 |
| US20220162692A1 (en) * | 2018-07-30 | 2022-05-26 | Oxford University Innovation Limited | Assemblies |
| US11162935B2 (en) | 2018-08-24 | 2021-11-02 | University Of Notre Dame Du Lac | Systems and methods for separating, detecting, and quantifying a target polynucleotide |
| BR112021004675A2 (pt) | 2018-09-11 | 2021-06-01 | Rijksuniversiteit Groningen | nanoporos biológicos com diâmetros de poros ajustáveis e usos dos mesmos como ferramentas analíticas |
| CN112280875B (zh) * | 2019-07-22 | 2023-07-18 | 四川大学华西医院 | 一种利用纳米孔进行细菌耐药性的快速检测方法、装置和系统 |
| WO2021086134A1 (ko) * | 2019-11-01 | 2021-05-06 | 한국생명공학연구원 | 나노포어를 이용한 병원성 미생물의 검출 방법 및 검출키트 |
| WO2021231920A1 (en) * | 2020-05-15 | 2021-11-18 | The Curators Of The University Of Missouri | Nanopore unzipping-sequencing for dna data storage |
| JP7679055B2 (ja) * | 2020-08-24 | 2025-05-19 | 国立大学法人東京農工大学 | 極低濃度のオリゴヌクレオチドの存在の有無を判定する方法、及び検査対象が特定疾患に罹患しているかどうか又は特定疾患罹患のリスクを有するかどうかを判定する方法 |
| CN112795628B (zh) * | 2021-02-05 | 2024-02-23 | 南京邮电大学 | 基于固态纳米孔传感器的miRNA检测方法、检测探针及试剂盒 |
| CN112961906B (zh) * | 2021-02-05 | 2024-01-23 | 南京邮电大学 | 金纳米棒检测探针、制备方法、检测方法及其应用 |
| CN113189070B (zh) * | 2021-04-28 | 2024-01-16 | 香港理工大学 | 一种纳米探针及其制备方法和应用、循环肿瘤细胞的miRNAs的检测系统 |
| WO2024091124A1 (en) | 2022-10-28 | 2024-05-02 | Rijksuniversiteit Groningen | Nanopore-based analysis of proteins |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6362002B1 (en) | 1995-03-17 | 2002-03-26 | President And Fellows Of Harvard College | Characterization of individual polymer molecules based on monomer-interface interactions |
| AU8586298A (en) | 1997-07-25 | 1999-02-16 | University Of Massachusetts | Designed protein pores as components for biosensors |
| AU4033500A (en) | 1999-03-25 | 2000-10-09 | Hyseq, Inc. | Solution-based methods and materials for sequence analysis by hybridization |
| AU783675B2 (en) | 1999-09-07 | 2005-11-24 | Regents Of The University Of California, The | Methods of determining the presence of double stranded nucleic acids in a sample |
| WO2001059453A2 (en) | 2000-02-11 | 2001-08-16 | The Texas A & M University System | Biosensor compositions and methods of use |
| AU2002318386A1 (en) | 2001-06-21 | 2003-01-08 | Agilent Technologies, Inc. | Methods for characterization of nucleic acid molecules |
| DE60233574D1 (de) * | 2001-07-10 | 2009-10-15 | Univ R | Verfahren und zusammensetzungen zum nachweis des aktivierungszustands multipler proteine in einzelzellen |
| US20050019784A1 (en) | 2002-05-20 | 2005-01-27 | Xing Su | Method and apparatus for nucleic acid sequencing and identification |
| CA2533701A1 (en) | 2003-07-31 | 2005-02-17 | Isis Pharmaceuticals, Inc. | Oligomeric compounds and compositions for use in modulation of small non-coding rnas |
| WO2005017025A2 (en) | 2003-08-15 | 2005-02-24 | The President And Fellows Of Harvard College | Study of polymer molecules and conformations with a nanopore |
| US20050136408A1 (en) | 2003-12-19 | 2005-06-23 | May Tom-Moy | Methods and systems for characterizing a polymer |
| EP1784754A4 (en) | 2004-08-13 | 2009-05-27 | Harvard College | OPTI-NANOPORE DNA READING PLATFORM WITH ULTRAHOLE THROUGHPUT |
| KR101159072B1 (ko) | 2005-01-20 | 2012-06-25 | 삼성전자주식회사 | 나노포어를 이용한 생분자의 분리방법 |
| KR100707198B1 (ko) | 2005-06-27 | 2007-04-13 | 삼성전자주식회사 | 나노포어 및 핵산에 비특이적으로 결합하는 물질을 이용한고감도 핵산 검출 방법 |
| WO2007041621A2 (en) | 2005-10-03 | 2007-04-12 | Xingsheng Sean Ling | Hybridization assisted nanopore sequencing |
| KR100730350B1 (ko) | 2005-10-17 | 2007-06-19 | 삼성전자주식회사 | 표면처리된 나노포어를 이용한 ｄｎａ 검출방법 및검출장치 |
| EP1954838B1 (en) * | 2005-11-14 | 2014-02-26 | Life Technologies Corporation | Coded molecules for detecting target analytes |
| WO2007117832A2 (en) | 2006-03-12 | 2007-10-18 | Applera Corporation | Methods of detecting target nucleic acids |
| US8314220B2 (en) * | 2007-01-26 | 2012-11-20 | Agilent Technologies, Inc. | Methods compositions, and kits for detection of microRNA |
| WO2008097190A1 (en) * | 2007-02-05 | 2008-08-14 | Agency For Science, Technology And Research | Methods of electrically detecting a nucleic acid by means of an electrode pair |
| KR101521990B1 (ko) | 2007-04-04 | 2015-05-20 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 나노포어 사용을 위한 조성물, 장치, 시스템 및 방법 |
| EP3543357A1 (en) | 2007-05-08 | 2019-09-25 | Trustees of Boston University | Chemical functionalization of solid-state nanopores and nanopore arrays and applications thereof |
| GB0713143D0 (en) | 2007-07-06 | 2007-08-15 | Ucl Business Plc | Nucleic acid detection method |
| CA2700859A1 (en) | 2007-10-02 | 2009-04-09 | President And Fellows Of Harvard College | Capture, recapture, and trapping of molecules with a nanopore |
| US20090181390A1 (en) | 2008-01-11 | 2009-07-16 | Signosis, Inc. A California Corporation | High throughput detection of micrornas and use for disease diagnosis |
| WO2009092035A2 (en) | 2008-01-17 | 2009-07-23 | Sequenom, Inc. | Methods and compositions for the analysis of biological molecules |
| ATE530497T1 (de) | 2008-03-31 | 2011-11-15 | Sony Deutschland Gmbh | Verfahren zur herstellung einer membran mit konischer pore |
| EP2310534B1 (en) | 2008-07-07 | 2018-09-05 | Oxford Nanopore Technologies Limited | Base-detecting pore |
| US20100099198A1 (en) | 2008-07-11 | 2010-04-22 | Board Of Regents, The University Of Texas System | Apparatus and system for pattern recognition sensing for biomolecules |
| US20100148126A1 (en) | 2008-11-26 | 2010-06-17 | Board Of Regents, The University Of Texas System | Genomic sequencing using modified protein pores and ionic liquids |
| US20110003703A1 (en) | 2009-07-01 | 2011-01-06 | Charles Ma | Nucleic Acid Hybridization and Detection Using Enzymatic Reactions on a Microarray |
| WO2011014811A1 (en) | 2009-07-31 | 2011-02-03 | Ibis Biosciences, Inc. | Capture primers and capture sequence linked solid supports for molecular diagnostic tests |
| WO2011028494A2 (en) | 2009-08-24 | 2011-03-10 | Trustees Of Boston University | Label-free sensing of pna-dna complexes using nanopores |
| US8324914B2 (en) | 2010-02-08 | 2012-12-04 | Genia Technologies, Inc. | Systems and methods for characterizing a molecule |
| WO2011103424A2 (en) | 2010-02-19 | 2011-08-25 | The Trustees Of The University Of Pennsylvania | High-resolution analysis devices and related methods |
| WO2011126869A2 (en) | 2010-03-30 | 2011-10-13 | Trustees Of Boston University | Tools and method for nanopores unzipping-dependent nucleic acid sequencing |
| CA2805247C (en) * | 2010-07-14 | 2021-08-10 | The Curators Of The University Of Missouri | Nanopore-facilitated single molecule detection of nucleic acids |
| WO2012083249A2 (en) | 2010-12-17 | 2012-06-21 | The Trustees Of Columbia University In The City Of New York | Dna sequencing by synthesis using modified nucleotides and nanopore detection |
| WO2013121201A1 (en) | 2012-02-15 | 2013-08-22 | Oxford Nanopore Technologies Limited | Aptamer method |
-
2011
- 2011-07-14 CA CA2805247A patent/CA2805247C/en active Active
- 2011-07-14 EP EP11807539.9A patent/EP2593568B1/en active Active
- 2011-07-14 JP JP2013519840A patent/JP6016792B2/ja active Active
- 2011-07-14 AU AU2011279083A patent/AU2011279083B2/en active Active
- 2011-07-14 EP EP17157476.7A patent/EP3190193A1/en not_active Withdrawn
- 2011-07-14 WO PCT/US2011/044082 patent/WO2012009578A2/en not_active Ceased
- 2011-07-14 US US13/810,105 patent/US9395353B2/en active Active
-
2016
- 2016-06-15 US US15/183,152 patent/US9574228B2/en active Active
- 2016-07-13 US US15/209,443 patent/US10273527B2/en active Active
- 2016-08-04 JP JP2016154002A patent/JP6521916B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2593568A2 (en) | 2013-05-22 |
| US9574228B2 (en) | 2017-02-21 |
| JP2013540423A (ja) | 2013-11-07 |
| AU2011279083B2 (en) | 2015-03-26 |
| US20130220809A1 (en) | 2013-08-29 |
| CA2805247A1 (en) | 2012-01-19 |
| US20170002403A1 (en) | 2017-01-05 |
| US20160319333A1 (en) | 2016-11-03 |
| US9395353B2 (en) | 2016-07-19 |
| JP2017006135A (ja) | 2017-01-12 |
| JP6521916B2 (ja) | 2019-05-29 |
| EP3190193A1 (en) | 2017-07-12 |
| EP2593568B1 (en) | 2017-04-19 |
| WO2012009578A2 (en) | 2012-01-19 |
| AU2011279083A1 (en) | 2013-01-31 |
| WO2012009578A3 (en) | 2012-04-05 |
| US10273527B2 (en) | 2019-04-30 |
| EP2593568A4 (en) | 2014-03-05 |
| JP6016792B2 (ja) | 2016-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2805247C (en) | Nanopore-facilitated single molecule detection of nucleic acids | |
| Gu et al. | Detection of miRNAs with a nanopore single-molecule counter | |
| US20170096704A1 (en) | Dna sequencing by nanopore using modified nucleotides | |
| Tavallaie et al. | Toward biosensors for the detection of circulating microRNA as a cancer biomarker: an overview of the challenges and successes | |
| CA2906007C (en) | Encoded nanopore sensor for multiplex nucleic acids detection | |
| WO2016025477A1 (en) | Detection of nucleic acids | |
| WO2015021055A1 (en) | Base-pair specific inter-strand locks for genetic and epigenetic detection | |
| HK1185633B (en) | Nanopore-facilitated single molecule detection of nucleic acids | |
| HK1185633A (en) | Nanopore-facilitated single molecule detection of nucleic acids | |
| EP4225911A1 (en) | Ready-to-use nanopore platform for attomole dna/rna oligo detection using an osmium tagged complementary probe | |
| Mussi et al. | Solid state nanopores for gene expression profiling | |
| Manrao et al. | Determining the Resolution of Biological Porin Mspa for Nanopore Sequencing | |
| Wang | Characterization nucleic acids unwinding and exploring its application in miRNA detection in the nanopore | |
| Ivica | α-Hemolysin nanopore sensing of MicroRNA with electrolyte gradients |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20160629 |